Eton Pharmaceuticals, Inc. (ETON) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $12.79M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $2.41M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$1.36M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$1.48M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2022-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | $12.79M | (m) | $37.59M | (m) | -$5.00K* | $7.25M* | $12.18M | $993.00K | (m) | $140.00K |
|---|
| 2026-03-31 | Reported | (m) | $2.41M | (m) | $24.27M | (m) | $75.00K | $7.41M | $9.53M | $1.88M | (m) | $20.00K |
|---|
| 2025-09-30 | Reported | (m) | -$1.36M | (m) | $22.46M | (m) | $284.00K* | $12.03M* | $14.60M | $1.11M | (m) | -$28.00K |
|---|
| 2025-06-30 | Reported | (m) | -$1.48M | (m) | $18.93M | (m) | $0.00* | $7.96M* | $7.00M | $3.71M | (m) | $66.00K |
|---|
| 2025-03-31 | Reported | (m) | -$470.00K | (m) | $17.28M | (m) | $0.00 | $2.09M | $7.42M | $1.16M | (m) | $74.00K |
|---|
| 2024-09-30 | Reported | (m) | $509.00K | (m) | $10.32M | (m) | $0.00* | $2.95M* | $4.02M | $505.00K | (m) | -$126.00K |
|---|
| 2024-06-30 | Reported | (m) | -$2.94M | (m) | $9.07M | (m) | $0.00* | $1.25M* | $3.45M | $2.97M | (m) | $54.00K |
|---|
| 2024-03-31 | Reported | (m) | -$800.00K | (m) | $7.97M | (m) | $14.00K | -$2.47M | $2.96M | $651.00K | (m) | $0.00 |
|---|
| 2023-09-30 | Reported | (m) | -$548.00K | (m) | $7.03M | (m) | $0.00* | $873.00K* | $2.63M | $615.00K | (m) | $0.00 |
|---|
| 2023-06-30 | Reported | (m) | $3.88M | (m) | $12.00M | (m) | $0.00* | $7.10M* | $2.31M | $1.13M | (m) | $0.00 |
|---|
| 2023-03-31 | Reported | (m) | -$2.53M | (m) | $5.30M | (m) | $0.00 | -$1.55M | $1.96M | $535.00K | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | $1.08M | (m) | (m) | (m) | 12.65% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$2.88M | (m) | (m) | (m) | -89.50% | $0.00* | -$1.70M* | $1.20M | $744.00K | (m) | $0.00 |
|---|
| 2022-06-30 | Reported | -$1.32M | (m) | (m) | (m) | -17.97% | $11.00K* | $2.46M* | $2.75M | $690.00K | (m) | $0.00 |
|---|
| 2022-03-31 | Reported | -$5.07M | (m) | (m) | (m) | -232.81% | $15.00K | $1.22M | $849.00K | $1.62M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | $1.34M | (m) | (m) | (m) | 21.94% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$5.82M | (m) | (m) | (m) | -751.35% | $2.00K* | -$2.95M* | $654.00K | $2.68M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$2.3M | (m) | (m) | (m) | -75.02% | (m) | -$369.00K* | $174.00K | $1.99M | (m) | (m) |
|---|
| 2021-03-31 | Reported | $5.45M | (m) | (m) | (m) | 45.78% | (m) | $3.71M | $1.59M | $886.00K | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$6.27M | (m) | -$161.00K | (m) | $2.00K* | -$5.09M* | $144.00K | $2.83M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$4.54M | (m) | $20.00K | (m) | $0.00* | -$2.85M* | $28.00K | $1.61M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$8.88M | (m) | $99.00K | (m) | $4.00K | -$7.22M | $102.00K | $6.27M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$5.04M | (m) | $0.00* | (m) | $32.00K* | -$3.21M* | (m) | $3.42M | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$3.35M | (m) | $0.00* | (m) | $642.00K* | -$4.20M* | (m) | $1.44M | (m) | (m) |
|---|
| 2019-03-31 | Reported | (m) | -$7.55M | (m) | $500.00K | (m) | $388.00K | -$6.77M | (m) | $6.46M | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$2.37M | (m) | (m) | (m) | $50.00K* | -$2.29M* | (m) | $1.54M | (m) | (m) |
|---|
| 2018-06-30 | Reported | (m) | -$2.70M | (m) | (m) | (m) | $41.00K* | -$2.23M* | (m) | $1.71M | (m) | (m) |
|---|
| 2018-03-31 | Reported | (m) | -$2.96M | (m) | (m) | (m) | $91.00K | -$1.85M | (m) | $1.27M | (m) | (m) |
|---|
| 2017-09-30 | Reported | (m) | -$2.77M | (m) | (m) | (m) | (m) | (m) | (m) | $1.56M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$844.00K | (m) | $79.95M | (m) | $333.00K | $10.52M | $37.21M | $7.76M | (m) | $43.00K |
|---|
| 2024-12-31 | Reported | (m) | -$2.60M | (m) | $39.01M | (m) | $26.00K | $969.00K | $15.60M | $3.25M | (m) | $15.00K |
|---|
| 2023-12-31 | Reported | (m) | -$1.19M | (m) | $31.64M | (m) | $0.00 | $6.82M | $10.58M | $3.32M | (m) | $247.00K |
|---|
| 2022-12-31 | Reported | -$8.19M | (m) | (m) | (m) | -38.56% | $38.00K | $4.82M | $6.93M | $4.00M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$1.34M | (m) | (m) | (m) | -6.14% | $9.00K | -$4.72M | $2.83M | $6.24M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$26.76M | (m) | (m) | (m) | -68625.64% | $50.00K | -$22.35M | $436.00K | $14.10M | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$18.32M | (m) | (m) | (m) | -1910.11% | $1.10M | -$18.03M | $453.00K | $11.55M | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$10.32M | (m) | (m) | (m) | $236.00K | -$8.14M | (m) | $5.63M | (m) | (m) |
|---|